Web26 rows · Mar 22, 2024 · Biomarin Pharmaceutical Market Cap: 17.44B for March 29, 2024. Market Cap Chart. Historical Market Cap Data. View and export this data back to … WebApr 9, 2024 · BioMarin Pharmaceutical Inc. has a 12-month low of $70.73 and a 12-month high of $117.77. The company has a market cap of $18.58 billion, a PE ratio of 134.59 and a beta of 0.38. The stock has a 50 day simple moving average of $100.53 and a 200-day simple moving average of $98.13.
BioMarin Pharmaceutical Overview StatMuse Money
WebGet the latest Biomarin Pharmaceutical Inc (BMRN) real-time quote, historical performance, charts, and other financial information to help you make more informed … WebBioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research … how to change name on ttrs
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Bought …
WebMarket Cap: $17.4B: Shares Short: 7M: Financials See more. Revenue (12 Mos) $2B: Revenue Growth (YoY) 19.5%: ... BioMarin’s stock falls after another company’s dwarfism drug moves into Phase 3 clinical trials. ... 770 Lindaro Street, San Rafael, CA, United States, 94901: Sector: Healthcare: Industry: Biotechnology: Full-Time Employees ... WebApr 13, 2024 · The business’s fifty day moving average price is $99.47 and its 200 day moving average price is $98.40. The firm has a market capitalization of $18.27 billion, a … WebFeb 27, 2024 · BioMarin, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $537.54 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate... how to change name on udemy certificate